Voodoo Doughnut is continuing its support of the Alzheimer’s Foundation of America (AFA) this year with its latest cherry cola flavored “Giving Doughnut.” As part of its quarterly give-back campaign, Voodoo Doughnut introduced the cherry cola doughnut. Voodoo said a portion of proceeds will benefit AFA’s mission to provide critical programs, services and research for those affected by Alzheimer’s disease and related dementias. 

This doughnut is the latest initiative of an ongoing partnership between Voodoo Doughnut and AFA, dating back several years. The two previously partnered in 2021 with the release of the limited edition “Homer Doughnut” on national doughnut day.  

“The Alzheimer’s Foundation of America is grateful for Voodoo Doughnut’s generosity as its customers will once again be raising funds to support our programs and services for families affected by Alzheimer’s disease and other dementia-related illnesses,” said Charles J. Fuschillo Jr., president and CEO of the Alzheimer’s Foundation of America. “Every dollar raised through this collaboration will make a difference by providing help and hope to families caring for a loved one with dementia.”

The cherry cola doughnut is covered in cola frosting, contains bright cherry filling and topped with sweet fluff and a cola candy. This limited-edition doughnut is available atarticipating Voodoo Doughnut locations now through July 7. 

AFA provides multiple resources for Alzheimer’s and dementia caregivers including a national toll-free helpline, caregiver support groups, educational tools, a Care Connect webinar series, the AFA Teal Room and more.  

Additionally, the foundation provides funding for research projects that are aimed at improving treatment and quality of life for those living with Alzheimer’s and dementia. Some of those projects include: 

“Alzheimer’s impacts so many lives in different ways, and we’re honored to support the work of the Alzheimer’s Foundation of America,” said Chris Schultz, Voodoo Doughnut CEO. “Their efforts bring hope and resources to individuals and families facing this disease, and we’re humbled to continue our partnership in support of their vital mission.”